Idiopathic pulmonary fibrosis: Physicians' perceptions of patient treatment with recently approved drugs
نویسندگان
چکیده
منابع مشابه
Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis: A Chance for a Multidisciplinary Treatment Approach
Background and Objectives: Idiopathic pulmonary fibrosis (IPF) is characterized by progressively worsening lung function, ventilation capacity, dyspnea, and finally reduced exercise intolerance. All of these have a significant negative impact on functional capacity and quality of life. In this study, we aim to evaluate the effects of pulmonary rehabilitation (PR) in IPF and assess the predictor...
متن کاملPerceptions, experiences and needs of patients with idiopathic pulmonary fibrosis.
AIMS To understand the perceptions, needs and experiences of patients with Idiopathic Pulmonary Fibrosis. BACKGROUND Idiopathic pulmonary fibrosis is a progressive interstitial lung disease, with a mean life expectancy similar to some forms of cancer of 2-4 years from diagnosis. Unlike the cancer literature, which is rich with studies exploring the needs of their disease group, few publicatio...
متن کاملREPORT OF FOUR CASES OF FAMILIAL IDIOPATHIC PULMONARY FIBROSIS
A 25 year old male and his 46 year old aunt presented with shortness of breath and a dramatic response to steroids. The other two patients are sisters with more advanced disease. One of these responded partially to steroids, while the other died within 4 months of treatment. The genetic basis and pathogenesis are discussed.
متن کاملManagement of a patient with familial idiopathic pulmonary fibrosis.
Idiopathic pulmonary fibrosis (IPF), the most common subtype of idiopathic interstitial pneumonia, is a chronic progressive lung disease with a very high mortality. Usually diagnosis is established in adults older than 50 years and most cases are considered to be sporadic. Individuals with a familial form of IPF have at least one affected member in the same primary biological family and account...
متن کاملPirfenidone treatment of idiopathic pulmonary fibrosis
Idiopathic pulmonary fibrosis (IPF) is a discrete clinicopathologic entity defined by the presence of usual interstitial pneumonia on high-resolution CT scan and/or open lung biopsy and the absence of an alternate diagnosis or exposure explaining these findings. There are currently no FDA-approved therapies available to treat this disease, and the 5-year mortality is ∼80%. The pyridone derivati...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Contemporary Clinical Trials Communications
سال: 2016
ISSN: 2451-8654
DOI: 10.1016/j.conctc.2016.04.008